Ambi, Shirly .

HRN: 25-27-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2024
CEFTRIAXONE 1G (VIAL)
08/05/2024
08/11/2024
IVT
1g
Q12hrs
Uti
Waiting Final Action 
08/19/2024
CEFUROXIME 1.5GM (VIAL)
08/19/2024
08/21/2024
IV
1.5 Grams
Q8 X 3 Days
SP 1LTCS
Waiting Final Action 
08/20/2024
CEFUROXIME 500MG (TAB)
08/20/2024
08/26/2024
PO
500mg
BID
Post Cs
Waiting Final Action 
08/21/2024
METRONIDAZOLE 500MG (TAB)
08/21/2024
08/27/2024
PO
500 Mg
BID
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: